Article Text

other Versions

PDF
Mephedrone toxicity in a Scottish emergency department
  1. Luke Regan1,
  2. Mark Mitchelson2,
  3. Catriona Macdonald2
  1. 1The Emergency Department of ARI Aberdeen Royal Infirmary, Aberdeen, UK
  2. 2Emergency Department, Aberdeen Royal Infirmary, Aberdeen, UK
  1. Correspondence to Dr Luke Regan, Aberdeen Royal Infirmary, Foresterhill, Aberdeen AB25 2ZN, UK; lukeregan{at}hotmail.com

Abstract

Objective To review and improve the evidence base regarding the toxic effects of Mephedrone, a cathinone derivative which was first believed to have been synthesised and propagated in 2007. On the 7th April 2010 the Misuse of Drugs Act 1971 (Amendment) Order 2010 was passed, declaring 4-Methylmethcathinone and other substituted cathinones Class B drugs as of 16 April 2010. This took place despite a perceived lack of evidence as to its potential harms.

Methods We undertook a critical review of the available literature to see what evidence existed for the potential effects of mephedrone ingestion. We then conducted our own retrospective consecutive case series of all patients presenting to the Aberdeen Royal Infirmary Emergency Department from the 1st December until the 16th April (the date at which Mephedrone was officially proscripted). The notes were examined for amounts, timings, sources and reasons for ingestion. Symptoms, biometric, ECG and blood analysis data were also recorded along with management and disposal outcomes.

Results 11 articles relating to mephedrone toxicity were identified and reviewed. 89 subjects were found for our case series. This compared to only 27 patients presenting with ingestion of substances (heroin, cocaine, cannabis) at that time illegal. 30 patients stated ingestion of mephedrone in isolation and a further 27 patients stated ingestion of mephedrone with alcohol in addition.

Conclusion A profile of largely psychoactive and cardiovascular toxicity is described with drug naivety perhaps explaining the high rates of bingeing and addiction reported.

  • Adverse effects
  • audit
  • cathinone
  • central nervous system stimulants
  • clinical assessment
  • designer drugs
  • drug abuse
  • mental health
  • mephedrone
  • poisoning
  • street drugs
  • toxicology

Statistics from Altmetric.com

Footnotes

  • Competing interests None declared.

  • Provenance and peer review Not commissioned; externally peer reviewed.

Request permissions

If you wish to reuse any or all of this article please use the link below which will take you to the Copyright Clearance Center’s RightsLink service. You will be able to get a quick price and instant permission to reuse the content in many different ways.

Linked Articles

  • Primary survey
    Malcolm Woollard